FrancophonIA/ELRC3.0 huggingface dataset:
English: Zalmoxis can only be obtained with a prescription and treatment is given under the supervision of a doctor who has experience in the treatment of blood cancers using HSCT.
Croatian: Lijek Zalmoxis izdaje se samo na liječnički recept, a liječenje mora biti pod nadzorom liječnika s iskustvom u liječenju raka krvi HSCT-om.
English: Zalmoxis is used in patients who have received a haploidentical HSCT because they have serious blood cancers, such as certain leukaemias and lymphomas.
Croatian: Zalmoxis se primjenjuje u bolesnika podvrgnutih haploidentičnom HSCT-u jer imaju ozbiljan rak krvi, kao što je leukemija ili limfom.
English: Graftversus-host disease occurred in 10 patients who were then given ganciclovir or valganciclovir, either alone or in combination with other medicines.
Croatian: Reakcija presatka protiv primatelja pojavila se u 10 bolesnika kojima je tada dan ganciklovir i valganciklovir kao monoterapija ili ti lijekovi u kombinaciji s nekim drugim lijekovima.
English: Zalmoxis has been investigated in a main study involving 30 patients who had haploidentical HSCT for serious blood cancers.
Croatian: Lijek Zalmoxis ispitivan je u okviru jednog glavnog ispitivanja koje je uključivalo 30 bolesnika koji su bili podvrgnuti HSCT-u zbog ozbiljnog raka krvi.
English: Zalmoxis has been shown to help restore the immune systems of patients who had haploidentical HSCT for serious blood cancers; these patients have limited treatment options and a poor prognosis.
Croatian: Pokazalo se da lijek Zalmoxis pomaže u obnovi imunološkog sustava bolesnika podvrgnutih HSCT-u zbog ozbiljnog raka krvi koji imaju ograničene mogućnosti liječenja i lošu prognozu.
English: For practical information about using Zalmoxis, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o primjeni lijeka Zalmoxis bolesnici trebaju pročitati u uputi o lijeku, odnosno obratiti se svom liječniku ili ljekarniku.
English: How does Zalmoxis work?
Croatian: Kako djeluje Zalmoxis?
English: For the full list of restrictions and side effects reported with Zalmoxis, see the package leaflet.
Croatian: Potpuni popis svih ograničenja i nuspojava zabilježenih pri primjeni lijeka Zalmoxis potražite u uputi o lijeku.
English: To make Zalmoxis, T cells from the HSCT donor are separated from the rest of the cells in the transplant.
Croatian: U proizvodnji lijeka Zalmoxis T-stanice donora odvajaju se od ostalih transplantiranih stanica.
English: Before receiving an HSCT, the patient will have received treatment to remove existing cells from the bone marrow, including cancer cells and immune cells.
Croatian: Bolesnik prije podvrgavanja HSCT-u prima terapiju radi uklanjanja postojećih stanica iz koštane srži, uključujući stanice raka i stanice imunološkog sustava.
English: How is Zalmoxis used?
Croatian: Kako se Zalmoxis koristi?
English: What benefits of Zalmoxis have been shown in studies?
Croatian: Koje su koristi lijeka Zalmoxis utvrđene u ispitivanjima?
English: If the patient develops graftversus-host disease, ganciclovir or valganciclovir is given, which kills the T cells that have the suicide gene thereby treating the disease and preventing its further development.
Croatian: Ako bolesnik razvije reakciju presatka protiv primatelja, za liječenje bolesti i sprječavanje njezina daljnjeg razvoja upotrebljavaju se ganciklovir ili valganciklovir, koji su namijenjeni uništavanju T-stanica s „genom samoubojicom”.
English: Two doses of the vaccine are recommended and the child should receive the second dose at least 4 weeks after the first.
Croatian: Preporučene su dvije doze cjepiva, a djeca drugu dozu trebaju primiti 4 tjedna nakon prve.
English: The dose is one spray (0.1 ml) into each nostril.
Croatian: Doza je jedan potisak (0,1 ml) u svaku nosnicu.
English: A vaccine against a specific disease ‘teaches' the immune system (the body's natural defences) to defend itself against the disease.
Croatian: Cjepivo protiv određene bolesti „uči” imunosni sustav (prirodnu obranu tijela) da se bori protiv bolesti.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) noted that preparing for a potential flu pandemic in children and adolescents meets an important medical need.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) pri Agenciji smatra da priprema za moguću pandemiju gripe kod djece i adolescenata zadovoljava važnu medicinsku potrebu.
English: Most people will not have come into contact with it and therefore will not have built up protection (‘immunity') against it.
Croatian: Većina ljudi s tim virusom nije bila u kontaktu i stoga neće imati razvijenu zaštitu (imunitet) od njega.
English: It should be given in an officially declared pandemic and according to official guidance.
Croatian: Treba ga primjenjivati nakon službenog proglašenja pandemije i u skladu sa službenim uputama.
English: A flu pandemic occurs when a new strain of flu virus appears that can spread easily because people have no immunity (protection) against it.
Croatian: Do pandemije gripe dolazi kad se pojavi novi soj virusa gripe koji se lako širi jer ljudi protiv njega nemaju razvijen imunitet (zaštitu).
English: A flu pandemic can affect people worldwide and cause many deaths.
Croatian: Pandemija gripe može ugroziti ljude diljem svijeta i izazvati značajnu smrtnost.
English: Thus, the CHMP decided that the benefits of the medicine in children aged 1 to 18 years are greater than its risks and recommended that it be given marketing authorisation.
Croatian: Stoga je CHMP odlučio da koristi od lijeka u djece u dobi od 1 do 18 godina nadmašuju s njim povezane rizike te je preporučio da mu se izda odobrenje za stavljanje u promet.
English: This helps to protect against the flu that the virus causes.
Croatian: Time se stvara zaštita od gripe koju uzrokuje virus.
English: It can particularly affect children who have not had seasonal flu or received flu vaccines previously.
Croatian: Ona osobito može pogoditi djecu koja nisu preboljela sezonsku gripu niti su prethodno cijepljena protiv gripe.
English: However, in a pandemic, it might be appropriate to give it to children with allergies if facilities for medical treatment of severe allergic reactions are immediately available.
Croatian: Međutim, u pandemiji bi ga se moglo dati djeci s alergijama ako je centar za medicinsko liječenje jakih alergijskih reakcija izravno dostupan.
English: However, a second vaccine that acts in a different way is able to make antibodies that can be measured easily.
Croatian: Međutim, drugo cjepivo s drugačijim djelovanjem stvara protutijela koja je lako izmjeriti.
English: The immune system will then be able to produce antibodies more quickly and in large numbers when it comes into contact with the virus again.
Croatian: Imunosni sustav potom će moći brže i u velikom broju proizvoditi protutijela kod ponovne izloženosti virusu.
English: When a child is given the vaccine, the immune system recognises the weakened virus in the vaccine as foreign and makes antibodies against it.
Croatian: Kad dijete primi cjepivo, imunosni sustav prepoznaje oslabljeni virus kao strano tijelo i protiv njega proizvodi protutijela.
English: This means that there is more evidence to come about the medicine, which the company is required to provide.
Croatian: To znači da je tvrtka dužna dostaviti više dokaza o lijeku.
English: The full EPAR for Pandemic influenza vaccine H5N1 AstraZeneca can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za Cjepivo protiv pandemijske influence H5N1 AstraZeneca nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The vaccine is expected to protect children against pandemic flu, on the basis of data obtained with this vaccine in adults.
Croatian: Očekuje se da će cjepivo zaštititi djecu od pandemije gripe na temelju podataka dobivenih o ovom cjepivu kod odraslih osoba.
English: The results were similar to those from three other studies involving 170 adults given pandemic preparedness vaccines containing similar types of bird flu virus, such as H7N9 and H7N7, instead of H5N1.
Croatian: Rezultati su bili slični onima iz drugih triju ispitivanja koja su uključivala 170 odraslih osoba koje su umjesto cjepiva s virusom H5N1 primile preventivno cjepivo za slučaj pandemije sa sličnim vrstama virusa ptičje gripe, kao što su H7N9 i H7N7.
English: This is further supported by data in children given similar seasonal and pandemic live attenuated flu vaccines in large studies and in clinical practice.
Croatian: To je dodatno potkrijepljeno podatcima u djece koja su primila slična sezonska i pandemijska živa atenuirana cjepiva u velikim ispitivanjima i kliničkoj praksi.
English: In those who received the second vaccine 3 weeks to 5 years after vaccination with Pandemic influenza vaccine H5N1 AstraZeneca, antibodies increased 4-fold in 73% (8 out of 11) of the individuals compared with 10% of the individuals who had not been previously vaccinated with Pandemic influenza vaccine H5N1 AstraZeneca.
Croatian: U osoba koje su primile drugo cjepivo u razdoblju od tri tjedna do pet godina nakon cijepljenja Cjepivom protiv pandemijske influence H5N1 AstraZeneca, protutijela su se povećala četiri puta u 73 % (8 od 11) osoba, u usporedbi s 10 % osoba koje prethodno nisu bile cijepljene Cjepivom protiv pandemijske influence H5N1 AstraZeneca.
English: This vaccine is intended to help with the management of a future pandemic.
Croatian: Cjepivom se želi lakše upravljati budućom pandemijom.
English: Instead, a pandemic preparedness vaccine can be made to contain a bird flu virus strain that could potentially cause a future pandemic.
Croatian: Umjesto toga, preventivno cjepivo za slučaj pandemije sadrži soj virusa ptičje gripe koji potencijalno može izazvati buduću pandemiju.
English: It is not possible to prepare a vaccine for a future pandemic because the strain of the pandemic flu virus is not known in advance.
Croatian: Nije moguće pripremiti cjepivo za buduću pandemiju jer soj virusa gripe koji uzrokuje pandemiju nije unaprijed poznat.
English: Testing this pandemic preparedness vaccine helps to predict how people will react to the vaccine at the time of a pandemic, when the virus strain in the vaccine will be replaced by a weakened version of the actual strain causing the pandemic.
Croatian: Testiranje preventivnog cjepiva za slučaj pandemije doprinosi procjeni broja ljudi koji će reagirati na cjepivo u vrijeme pandemije, kad će se soj virusa iz cjepiva zamijeniti oslabljenom verzijom onog soja koji uzrokuje pandemiju.
English: Pandemic influenza vaccine H5N1 AstraZeneca must not generally be given to children who have had a severe allergic reaction to any of the substances in the vaccine including gelatin and gentamicin or to children who have had a severe allergic reaction to eggs or egg proteins, such as ovalbumin.
Croatian: Cjepivo protiv pandemijske influence H5N1 AstraZeneca u pravilu se ne smije davati djeci koja su imala jake alergijske reakcije na bilo koji sastojak cjepiva, uključujući želatinu i gentamicin, niti djeci koja su imala jake alergijske reakcije na jaja i bjelančevine jaja, poput ovalbumina.
English: Because a new pandemic live attenuated vaccine cannot be tested in children, the benefit of this vaccine in children was predicted from studies in adults and from studies of similar live attenuated flu vaccines in children.
Croatian: Budući da se novo živo atenuirano cjepivo protiv pandemije ne može ispitivati na djeci, koristi ovog cjepiva za djecu procijenjene su na temelju ispitivanja na odraslim osobama i ispitivanja sličnih živih atenuiranih cjepiva protiv gripe na djeci.
English: In addition, there is evidence indicating that the vaccine can protect against different strains of H5N1 virus.
Croatian: Osim toga, postoje dokazi koji ukazuju na to da je cjepivo djelotvorno protiv različitih sojeva virusa H5N1.
English: The most common side effects with Pandemic influenza vaccine H5N1 AstraZeneca (which may affect more than 1 in 10 people) are decreased appetite, headache, runny or stuffy nose, and feeling unwell.
Croatian: Najčešće nuspojave Cjepiva protiv pandemijske influence H5N1 AstraZeneca (koje se mogu javiti u više od 1 na 10 osoba) su smanjeni apetit, glavobolja, hunjavica ili začepljen nos i opće loše stanje.
English: This showed that antibodies against Pandemic influenza vaccine H5N1 AstraZeneca increased substantially when vaccinated adults came into contact with the virus again.
Croatian: To pokazuje da su se protutijela na Cjepivo protiv pandemijske influence H5N1 AstraZeneca značajno povećala kad su cijepljene odrasle osobe ponovo došle u kontakt s virusom.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Pandemic influenza vaccine H5N1 MedImmune on 20 May 2016.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za Cjepivo protiv pandemijske influence H5N1 MedImmune na snazi u Europskoj uniji od 20. svibnja 2016.
English: Pandemic influenza vaccine H5N1 AstraZeneca is a vaccine developed to protect children aged between 12 months and 18 years against influenza (flu) during a flu pandemic.
Croatian: Cjepivo protiv pandemijske influence H5N1 AstraZeneca cjepivo je razvijeno za zaštitu djece u dobi između 12 mjeseci i 18 godina starosti protiv influence (gripe) za vrijeme pandemije gripe.
English: The name of the medicine was changed to Pandemic influenza vaccine H5N1 AstraZeneca on 24 May 2017.
Croatian: Naziv lijeka promijenjen je u Cjepivo protiv pandemijske influence H5N1 AstraZeneca 24. svibnja 2017.
English: Although Pandemic influenza vaccine H5N1 AstraZeneca might increase wheezing in children aged 1 to 2 years, the risk is considered acceptable in a pandemic situation.
Croatian: Iako Cjepivo protiv pandemijske influence H5N1 AstraZeneca može pojačati piskanje pri disanju u djece u dobi od 1 do 2 godine, taj se rizik smatra prihvatljivim u vrijeme pandemije.
English: Since Pandemic influenza vaccine H5N1 AstraZeneca has been granted a conditional approval, the company that markets Pandemic influenza vaccine H5N1 AstraZeneca will conduct studies to gather more information on its effectiveness and side effects during its use in a pandemic as well as its shelf life.
Croatian: Kako je Cjepivu protiv pandemijske influence H5N1 AstraZeneca izdano uvjetno odobrenje, tvrtka koja Cjepivo protiv pandemijske influence H5N1 AstraZeneca stavlja u promet provest će ispitivanja kako bi prikupila dodatne informacije o njegovoj djelotvornosti i nuspojavama tijekom primjene u vrijeme pandemije kao i o njegovu roku trajanja.
English: In addition, the company presented extensive supportive data from large studies and from clinical practice on how well other similar pandemic and seasonal live attenuated influenza A vaccines work in children.
Croatian: Nadalje, navedena je tvrtka dostavila opsežne podatke iz velikih ispitivanja i kliničke prakse koji su potvrdili da su druga slična pandemijska i sezonska živa atenuirana cjepiva protiv influence tipa
English: For the full list of restrictions, see the package leaflet.
Croatian: Potpuni popis ograničenja potražite u uputi o cjepivu.
English: Further studies on the effects on the vaccine in children will need to be provided once the the flu strain causing the pandemic is included in the vaccine.
Croatian: Daljnja ispitivanja učinaka cjepiva na djecu pružit će se nakon što se soj virusa gripe koji je uzročnik pandemije doda u cjepivo.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Pandemic influenza vaccine H5N1 AstraZeneca have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene Cjepiva protiv pandemijske influence H5N1 AstraZeneca nalaze se u sažetku opisa svojstava i u uputi o cjepivu.
English: For more information about prevention of influenza with Pandemic influenza vaccine H5N1 AstraZeneca, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o suzbijanju gripe Cjepivom protiv pandemijske influence H5N1 AstraZeneca pročitajte u uputi o cjepivu (također dio EPAR-a), odnosno obratite se svom liječniku ili ljekarniku.
English: This is a summary of the European public assessment report (EPAR) for Pandemic influenza vaccine H5N1 AstraZeneca.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) Cjepiva protiv pandemijske influence H5N1 AstraZeneca.
English: Three main studies involving 107 adults found that Pandemic influenza vaccine H5N1 AstraZeneca was able to prepare the immune system to defend itself against the H5N1 virus strain in individuals who had never come into contact with it. Antibodies against this type of vaccine are not easy to measure.
Croatian: U tri glavna ispitivanja na 107 odraslih osoba utvrđeno je da je Cjepivo protiv pandemijske influence H5N1 AstraZeneca pripremilo imunosni sustav da se bori protiv soja virusa H5N1 u osoba koje mu prije nikad nisu bile izložene.
English: Previously known as Pandemic influenza vaccine H5N1 MedImmune
Croatian: Prethodni naziv: Cjepivo protiv pandemijske influence H5N1 MedImmune
English: What measures are being taken to ensure the safe and effective use of Pandemic influenza vaccine H5N1 AstraZeneca?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena Cjepiva protiv pandemijske influence H5N1 AstraZeneca?
English: For practical information about using Pandemic influenza vaccine H5N1 AstraZeneca, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o primjeni Cjepiva protiv pandemijske influence H5N1 AstraZeneca bolesnici trebaju pročitati u uputi o cjepivu, odnosno obratiti se svom liječniku ili ljekarniku.
English: Pandemic influenza vaccine H5N1 AstraZeneca has been given ‘conditional approval'.
Croatian: Cjepivu protiv pandemijske influence H5N1 AstraZeneca izdano je „uvjetno odobrenje”.
English: Other information about Pandemic influenza vaccine H5N1 AstraZeneca
Croatian: Ostale informacije o Cjepivu protiv pandemijske influence H5N1 AstraZeneca
English: It is not intended to provide practical advice on how to use Pandemic influenza vaccine H5N1 AstraZeneca.
Croatian: Svrha sažetka nije davati praktične savjete o primjeni Cjepiva protiv pandemijske influence H5N1 AstraZeneca.
English: What is Pandemic influenza vaccine H5N1 AstraZeneca and what is it used for?
Croatian: Što je Cjepivo protiv pandemijske influence H5N1 AstraZeneca i za što se koristi?
English: For the full list of all side effects reported with Pandemic influenza vaccine H5N1 AstraZeneca, see the package leaflet.
Croatian: Potpuni popis nuspojava zabilježenih pri primjeni Cjepiva protiv pandemijske influence H5N1 AstraZeneca potražite u uputi o cjepivu.
English: Pandemic influenza vaccine H5N1 AstraZeneca is a pandemic preparedness vaccine.
Croatian: Cjepivo protiv pandemijske influence H5N1 AstraZeneca je preventivno cjepivo za slučaj pandemije.
English: What are the risks associated with Pandemic influenza vaccine H5N1 AstraZeneca?
Croatian: Koji su rizici povezani s Cjepivom protiv pandemijske influence H5N1 AstraZeneca?
English: Why is Pandemic influenza vaccine H5N1 AstraZeneca approved?
Croatian: Zašto je Cjepivo protiv pandemijske influence H5N1 AstraZeneca odobreno?
English: Pandemic influenza vaccine H5N1 AstraZeneca is available as a nasal spray.
Croatian: Cjepivo protiv pandemijske influence H5N1 AstraZeneca dostupno je kao sprej za nos.
English: pandemic influenza vaccine (H5N1) (live attenuated, nasal)
Croatian: Cjepivo protiv pandemijske influence H5N1 AstraZeneca cjepivo protiv pandemijske influence (H5N1) (živo atenuirano, nazalno)
English: What benefits of Pandemic influenza vaccine H5N1 AstraZeneca have been shown in studies?
Croatian: Koje su koristi Cjepiva protiv pandemijske influence H5N1 AstraZeneca utvrđene u ispitivanjima?
English: Pandemic influenza vaccine H5N1 AstraZeneca contains live, attenuated (weakened) influenza A virus A/Vietnam/1203/2004 (H5N1) strain.
Croatian: Cjepivo protiv pandemijske influence H5N1 AstraZeneca sadrži živi atenuirani (oslabljeni) soj virusa influence tipa
English: • hypertension;
Croatian: • hipertenziju;
English: Plendil has been approved through national procedures in the following countries in the European Economic Area (EEA): Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Spain, Sweden and the United Kingdom.
Croatian: U Europskom gospodarskom prostoru (EGP): Austriji, Belgiji, Bugarskoj, Hrvatskoj, Cipru, Češkoj Republici, Danskoj, Estoniji, Finskoj, Francuskoj, Njemačkoj, Grčkoj, Mađarskoj, Islandu, Irskoj, Italiji, Latviji, Litvi, Luksemburgu, Malti, Nizozemskoj, Norveškoj, Poljskoj, Portugalu, Rumunjskoj, Slovačkoj, Španjolskoj, Švedskoj i Ujedinjenoj Kraljevini.
English: Therefore such combinations should be avoided (see section 4.5).'
Croatian: Stoga, ovu kombinaciju treba izbjegavati (vidjeti dio 4.5).“
English: This formulation was available until 1994, though only launched in Australia.
Croatian: Ova je formulacija bila dostupna sve do 1994., iako je stavljena u promet samo u Australiji.
English: The following wording was agreed:
Croatian: Usuglašen je sljedeći tekst:
English: The proposal for the harmonised EU SmPC is based on the CPS from 2011 and CDS from October 2012.
Croatian: Prijedlog SPC-a usklađenog na razini EU temelji se na CPS-u iz 2011. i na CDS-u iz listopada 2012.
English: • stable angina pectoris.
Croatian: • stabilnu anginu pektoris.
English: The prolonged release tablet is available in three tablet strengths 2.5mg, 5mg and 10mg.
Croatian: Tableta s produljenim oslobađanjem dostupna je u tri jačine 2,5 mg, 5 mg i 10 mg.
English: For the indication “stable angina pectoris” there were several divergences.
Croatian: Za indikaciju „stabilna angina pektoris“ bilo je nekoliko divergencija.
English: The CHMP therefore considers it necessary to include the following text in Section 4.4, including a reference to Section 4.5:
Croatian: Stoga CHMP smatra neophodnim uključivanje sljedećeg teksta u dio 4.4, uključujući i referencu na dio 4.5:
English: This method generates the Empirical Bayesian Geometric Mean (EBGM) with a 90% confidence interval (EB05 to EB95).
Croatian: Ovom se metodom generira empirijska Bayesova geometrijska sredina (EBGM) s intervalom 90%-tne točnosti (EB05 do EB95).
English: In Europe, the prolonged release tablet was first approved in December 1987 and was first launched in Denmark in 1988.
Croatian: U Europi je tableta s produljenim oslobađanjem po prvi puta odobrena u prosincu 1987., a prvi put je stavljena u promet u Danskoj 1988.
English: Today, Plendil is available worldwide for oral administration as a prolonged release tablet (except in Japan where another immediate release tablet is marketed).
Croatian: Danas je Plendil dostupan diljem svijeta za peroralnu primjenu kao tableta s produljenim oslobađanjem (izuzev u Japanu gdje je u promet stavljena druga tableta s trenutnim oslobađanjem).
English: Some MSs were missing a text referring to absorption, distribution, metabolism and elimination.
Croatian: U pojedinim državama članicama nedostajao je tekst koji se odnosio na apsorpciju, distribuciju, metabolizam i eliminaciju.
English: Section 4.1 - Therapeutic Indications Plendil is indicated for:
Croatian: Dio 4.1 - Terapijske indikacije Plendil je indiciran za:
English: Plendil was originally approved for marketing in Denmark on 16 March 1987, as an immediate release tablet.
Croatian: Plendil je prvotno odobren za stavljanje u promet u Danskoj dana 16. ožujka 1987., kao tableta s trenutnim oslobađanjem.
English: The wording on section 4.8 was divergent.
Croatian: Tekst dijela 4.8 bio je divergentan.